This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, Y. Articles by Guan, K.-L. Search for Related Content PubMed PubMed Citation Articles by Li, Y. Articles by Guan, K.-L.

Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP Activity

Life Sciences Institute,¹ Department of Biological Chemistry,² Institute of Gerontology, University of Michigan, Ann Arbor, Michigan³

Received 18 May 2004/ Accepted 15 June 2004

Tuberous sclerosis complex (TSC) is a genetic disease caused by a mutation in either the tsc1 or tsc2 tumor suppressor gene. Recent studies have demonstrated that TSC2 displays GAP (GTPase-activating protein) activity specifically towards the small G protein Rheb and inhibits its ability to stimulate the mTOR signaling pathway. Rheb and TSC2 comprise a unique pair of GTPase and GAP, because Rheb has high basal GTP levels and TSC2 does not have the catalytic arginine finger found in Ras-GAP. To investigate the function of TSC2 and Rheb in mTOR signaling, we analyzed the TSC2-stimulated Rheb GTPase activity. We found that Arg15, a residue equivalent to Gly12 in Ras, is important for Rheb to function as a substrate for TSC2 GAP. In addition, we identified asparagine residues essential for TSC2 GAP activity. We demonstrated a novel catalytic mechanism of the TSC2 GAP and Rheb that TSC2 uses a catalytic "asparagine thumb" instead of the arginine finger found in Ras-GAP. Furthermore, we discovered that farnesylation and membrane localization of Rheb is not essential for Rheb to stimulate S6 kinase (S6K) phosphorylation. Analysis of TSC1 binding defective mutants of TSC2 shows that TSC1 is not required for the TSC2 GAP activity but may function as a regulatory component in the TSC1/TSC2 complex. Our data further demonstrate that GAP activity is essential for the cellular function of TSC2 to inhibit S6K phosphorylation.

This article has been cited by other articles:

• Sun, Y., Fang, Y., Yoon, M.-S., Zhang, C., Roccio, M., Zwartkruis, F. J., Armstrong, M., Brown, H. A., Chen, J. (2008). Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc. Natl. Acad. Sci. USA 105: 8286-8291 [Abstract] [Full Text]  
• Habib, S. L., Riley, D. J., Mahimainathan, L., Bhandari, B., Choudhury, G. G., Abboud, H. E. (2008). Tuberin regulates the DNA repair enzyme OGG1. Am. J. Physiol. Renal Physiol. 294: F281-F290 [Abstract] [Full Text]  
• Li, Y., Wang, Y., Kim, E., Beemiller, P., Wang, C.-Y., Swanson, J., You, M., Guan, K.-L. (2007). Bnip3 Mediates the Hypoxia-induced Inhibition on Mammalian Target of Rapamycin by Interacting with Rheb. J. Biol. Chem. 282: 35803-35813 [Abstract] [Full Text]  
• Bai, X., Ma, D., Liu, A., Shen, X., Wang, Q. J., Liu, Y., Jiang, Y. (2007). Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38. Science 318: 977-980 [Abstract] [Full Text]  
• Finlay, G. A., Malhowski, A. J., Liu, Y., Fanburg, B. L., Kwiatkowski, D. J., Toksoz, D. (2007). Selective Inhibition of Growth of Tuberous Sclerosis Complex 2 Null Cells by Atorvastatin Is Associated with Impaired Rheb and Rho GTPase Function and Reduced mTOR/S6 Kinase Activity. Cancer Res. 67: 9878-9886 [Abstract] [Full Text]  
• Land, S. C., Tee, A. R. (2007). Hypoxia-inducible Factor 1{alpha} Is Regulated by the Mammalian Target of Rapamycin (mTOR) via an mTOR Signaling Motif. J. Biol. Chem. 282: 20534-20543 [Abstract] [Full Text]  
• Juvet, S. C., McCormack, F. X., Kwiatkowski, D. J., Downey, G. P. (2007). Molecular Pathogenesis of Lymphangioleiomyomatosis: Lessons Learned from Orphans. Am. J. Respir. Cell Mol. Bio. 36: 398-408 [Abstract] [Full Text]  
• Cao, Y., Kamioka, Y., Yokoi, N., Kobayashi, T., Hino, O., Onodera, M., Mochizuki, N., Nakae, J. (2006). Interaction of FoxO1 and TSC2 Induces Insulin Resistance through Activation of the Mammalian Target of Rapamycin/p70 S6K Pathway. J. Biol. Chem. 281: 40242-40251 [Abstract] [Full Text]  
• Matsushima, R., Harada, N., Webster, N. J. G., Tsutsumi, Y. M., Nakaya, Y. (2006). Effect of TRB3 on Insulin and Nutrient-stimulated Hepatic p70 S6 Kinase Activity. J. Biol. Chem. 281: 29719-29729 [Abstract] [Full Text]  
• Shah, O. J., Hunter, T. (2006). Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis.. Mol. Cell. Biol. 26: 6425-6434 [Abstract] [Full Text]  
• Yan, L., Findlay, G. M., Jones, R., Procter, J., Cao, Y., Lamb, R. F. (2006). Hyperactivation of Mammalian Target of Rapamycin (mTOR) Signaling by a Gain-of-Function Mutant of the Rheb GTPase. J. Biol. Chem. 281: 19793-19797 [Abstract] [Full Text]  
• Nakase, Y., Fukuda, K., Chikashige, Y., Tsutsumi, C., Morita, D., Kawamoto, S., Ohnuki, M., Hiraoka, Y., Matsumoto, T. (2006). A Defect in Protein Farnesylation Suppresses a Loss of Schizosaccharomyces pombe tsc2+, a Homolog of the Human Gene Predisposing to Tuberous Sclerosis Complex. Genetics 173: 569-578 [Abstract] [Full Text]  
• Goncharova, E. A., Goncharov, D. A., Spaits, M., Noonan, D. J., Talovskaya, E., Eszterhas, A., Krymskaya, V. P. (2006). Abnormal Growth of Smooth Muscle-Like Cells in Lymphangioleiomyomatosis: Role for Tumor Suppressor TSC2. Am. J. Respir. Cell Mol. Bio. 34: 561-572 [Abstract] [Full Text]  
• Cai, S.-L., Tee, A. R., Short, J. D., Bergeron, J. M., Kim, J., Shen, J., Guo, R., Johnson, C. L., Kiguchi, K., Walker, C. L. (2006). Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J. Cell Biol. 173: 279-289 [Abstract] [Full Text]  
• Kimball, S. R, Jefferson, L. S (2006). New functions for amino acids: effects on gene transcription and translation. Am. J. Clin. Nutr. 83: 500S-507S [Abstract] [Full Text]  
• Kaper, F., Dornhoefer, N., Giaccia, A. J. (2006). Mutations in the PI3K/PTEN/TSC2 Pathway Contribute to Mammalian Target of Rapamycin Activity and Increased Translation under Hypoxic Conditions. Cancer Res. 66: 1561-1569 [Abstract] [Full Text]  
• Tzatsos, A., Kandror, K. V. (2006). Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation. Mol. Cell. Biol. 26: 63-76 [Abstract] [Full Text]  
• Kimball, S. R., Jefferson, L. S. (2006). Signaling Pathways and Molecular Mechanisms through which Branched-Chain Amino Acids Mediate Translational Control of Protein Synthesis. J. Nutr. 136: 227S-231S [Abstract] [Full Text]  
• Zacharek, S. J., Xiong, Y., Shumway, S. D. (2005). Negative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins. Cancer Res. 65: 11354-11360 [Abstract] [Full Text]  
• Dekanty, A., Lavista-Llanos, S., Irisarri, M., Oldham, S., Wappner, P. (2005). The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-{alpha}/Sima. J. Cell Sci. 118: 5431-5441 [Abstract] [Full Text]  
• Takahashi, K., Nakagawa, M., Young, S. G., Yamanaka, S. (2005). Differential Membrane Localization of ERas and Rheb, Two Ras-related Proteins Involved in the Phosphatidylinositol 3-Kinase/mTOR Pathway. J. Biol. Chem. 280: 32768-32774 [Abstract] [Full Text]  
• Basso, A. D., Mirza, A., Liu, G., Long, B. J., Bishop, W. R., Kirschmeier, P. (2005). The Farnesyl Transferase Inhibitor (FTI) SCH66336 (lonafarnib) Inhibits Rheb Farnesylation and mTOR Signaling: ROLE IN FTI ENHANCEMENT OF TAXANE AND TAMOXIFEN ANTI-TUMOR ACTIVITY. J. Biol. Chem. 280: 31101-31108 [Abstract] [Full Text]  
• Sofer, A., Lei, K., Johannessen, C. M., Ellisen, L. W. (2005). Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1. Mol. Cell. Biol. 25: 5834-5845 [Abstract] [Full Text]  
• Long, X., Ortiz-Vega, S., Lin, Y., Avruch, J. (2005). Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency. J. Biol. Chem. 280: 23433-23436 [Abstract] [Full Text]  
• Gau, C.-L., Kato-Stankiewicz, J., Jiang, C., Miyamoto, S., Guo, L., Tamanoi, F. (2005). Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and -insensitive pathways. Molecular Cancer Therapeutics 4: 918-926 [Abstract] [Full Text]  
• Smith, E. M., Finn, S. G., Tee, A. R., Browne, G. J., Proud, C. G. (2005). The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular Stresses. J. Biol. Chem. 280: 18717-18727 [Abstract] [Full Text]  
• Yu, Y., Li, S., Xu, X., Li, Y., Guan, K., Arnold, E., Ding, J. (2005). Structural Basis for the Unique Biological Function of Small GTPase RHEB. J. Biol. Chem. 280: 17093-17100 [Abstract] [Full Text]  
• Scheidenhelm, D. K., Cresswell, J., Haipek, C. A., Fleming, T. P., Mercer, R. W., Gutmann, D. H. (2005). Akt-Dependent Cell Size Regulation by the Adhesion Molecule on Glia Occurs Independently of Phosphatidylinositol 3-Kinase and Rheb Signaling. Mol. Cell. Biol. 25: 3151-3162 [Abstract] [Full Text]  
• Inoki, K., Ouyang, H., Li, Y., Guan, K.-L. (2005). Signaling by Target of Rapamycin Proteins in Cell Growth Control. Microbiol. Mol. Biol. Rev. 69: 79-100 [Abstract] [Full Text]